Supplier profile
EurimPharm Arzneimittel GmbH
Every public-sector award we hold for this supplier, across Germany, from 1 Dec 2017 to 6 Jul 2026.
Awards won
138
all time
Attributed value
€6
130 shared, unvalued
Buyers
7
public bodies
Active
2017–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| DAK-Gesundheit | 127 | not attributable |
| IKK classic | 4 | €4 |
| AOK PLUS – Die Gesundheitskasse für Sachsen und Thüringen | 2 | not attributable |
| Techniker Krankenkasse | 2 | €2 |
| AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | 1 | not attributable |
| Deutsche Rentenversicherung Knappschaft-Bahn-See | 1 | not attributable |
| GWQ ServicePlus AG, handelnd für die unter VI 2.) näher genannten Gesetzlichen Krankenkassen | 1 | not attributable |
What they win
Awards
Showing 126–138 of 138 awards we hold
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Naloxegol, ATC A06AH03 für die Zeit 01.08.2022 - 31.07.2024 ↗DAK-Gesundheitshared awardawarded 1 Aug 2022
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Bexaroten, ATC L01XX25 für die Zeit 01.06.2022 - 31.05.2024 ↗DAK-Gesundheitshared awardawarded 2 Jun 2022
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fondaparinux, ATC B01AX05 für die Zeit 01.06.2022 - 31.05.2024 ↗DAK-Gesundheitshared awardawarded 2 Jun 2022
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Fondaparinux, ATC B01AX05 für die Zeit 01.06.2022 - 31.05.2024 ↗DAK-Gesundheitshared awardawarded 1 Jun 2022
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Bexaroten, ATC L01XX25 für die Zeit 01.06.2022 - 31.05.2024 ↗DAK-Gesundheitshared awardawarded 1 Jun 2022
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Interferon beta-1b, ATC L03AB08 für die Zeit 01.04.2022 - 31.03.2024 ↗DAK-Gesundheitshared awardawarded 2 Apr 2022
- Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Filgrastim, ATC L03AA02 für die Zeit 01.04.2022 - 31.03.2024 ↗DAK-Gesundheitshared awardawarded 2 Apr 2022
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Filgrastim, ATC L03AA02 für die Zeit 01.04.2022 - 31.03.2024 ↗DAK-Gesundheitshared awardawarded 1 Apr 2022
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Interferon beta-1b, ATC L03AB08 für die Zeit 01.04.2022 - 31.03.2024 ↗DAK-Gesundheitshared awardawarded 1 Apr 2022
- Germany-Erfurt: Pharmaceutical products ↗AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringenshared awardawarded 20 Aug 2021
- Germany-Erfurt: Pharmaceutical products ↗AOK PLUS – Die Gesundheitskasse für Sachsen und Thüringenshared awardawarded 1 Jun 2021
- Germany-Erfurt: Pharmaceutical products ↗AOK PLUS – Die Gesundheitskasse für Sachsen und Thüringenshared awardawarded 8 Jan 2021
- Germany-Düsseldorf: Pharmaceutical products ↗GWQ ServicePlus AG, handelnd für die unter VI 2.) näher genannten Gesetzlichen Krankenkassenawarded 1 Dec 2017
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.